Oncolytics Biotech Statistics
Total Valuation
ONCY has a market cap or net worth of $42.68 million. The enterprise value is $32.47 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ONCY has 84.63 million shares outstanding. The number of shares has increased by 11.26% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 84.63M |
| Shares Change (YoY) | +11.26% |
| Shares Change (QoQ) | +9.10% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 83.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 9.45 |
| P/TBV Ratio | 9.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.21, with a Debt / Equity ratio of 0.15.
| Current Ratio | 3.21 |
| Quick Ratio | 2.67 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -213.85% and return on invested capital (ROIC) is -131.59%.
| Return on Equity (ROE) | -213.85% |
| Return on Assets (ROA) | -76.34% |
| Return on Invested Capital (ROIC) | -131.59% |
| Return on Capital Employed (ROCE) | -238.66% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$782,765 |
| Employee Count | 28 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ONCY has paid $90,444 in taxes.
| Income Tax | 90,444 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.53% in the last 52 weeks. The beta is 1.51, so ONCY's price volatility has been higher than the market average.
| Beta (5Y) | 1.51 |
| 52-Week Price Change | -57.53% |
| 50-Day Moving Average | 0.58 |
| 200-Day Moving Average | 0.85 |
| Relative Strength Index (RSI) | 39.49 |
| Average Volume (20 Days) | 249,491 |
Short Selling Information
| Short Interest | 2.23M |
| Short Previous Month | 2.69M |
| Short % of Shares Out | 2.68% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.93 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -23.14M |
| Pretax Income | -20.29M |
| Net Income | -21.92M |
| EBITDA | -23.07M |
| EBIT | -23.14M |
| Earnings Per Share (EPS) | -$0.28 |
Full Income StatementBalance Sheet
The company has $10.65 million in cash and $695,725 in debt, giving a net cash position of $9.95 million or $0.12 per share.
| Cash & Cash Equivalents | 10.65M |
| Total Debt | 695,725 |
| Net Cash | 9.95M |
| Net Cash Per Share | $0.12 |
| Equity (Book Value) | 4.52M |
| Book Value Per Share | 0.05 |
| Working Capital | 8.85M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$18.09 million and capital expenditures -$134,275, giving a free cash flow of -$18.76 million.
| Operating Cash Flow | -18.09M |
| Capital Expenditures | -134,275 |
| Free Cash Flow | -18.76M |
| FCF Per Share | -$0.22 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |